By Ms Nicki Susan Meagher

Preprints

Zwimpfer TA; Fereday S; Pandey A; Ariyaratne D; Jayawardana MW; Twomey L; Laumont CM; Kennedy CJ; Bolithon A; Meagher NS; Milne K; Hamilton P; Alsop J; Antoniou AC; Au-Yeung G; Beckmann MW; Berrington de Gonzalez A; Bisinotto C; Blome F; Bodelon C; Boros J; Brand AH; Carney ME; Cazorla-Jiménez A; Chiu DS; Christie EL; Chudecka-Głaz A; Coulson P; Cushing-Haugen KL; Cybulski C; Darcy KM; David C; Davidson T; Ekici AB; Elishaev E; Emons J; Engler T; Farrell R; Fischer A; García-Closas M; Gentry-Maharaj A; Ghatage P; Glasspool R; Harter P; Hartkopf AD; Hartmann A; Heikaus S; Hernandez BY; Hettiaratchi A; Heublein S; Huntsman DG; Jimenez-Linan M; Jones ME; Kang E; Kaznowska E; Kluz T; Kommoss FKF; Konecny G; Kruitwagen RFPM; Kwon J; Lambrechts D; Lee C-H; Lester J; Leung SCY; Leung Y; Linder A; Lissowska J; Loverix L; Lubiński J; Mateoiu C; McNeish IA; Moubarak M; Nelson GS; Nevins N; Olawaiye AB; Olbrecht S; Orsulic S; Osorio A; Quinn CM; Raj Mohan G; Ray-Coquard I; Rodríguez-Antona C; Roxburgh P; Ruebner M; Salfinger SG; Samra S; Schoemaker MJ; Sinn H-P; Sonke GS; Steele L; Stewart CJR; Talhouk A; Tan A; Tarney CM; Taylor SE; Van de Vijver KK; van der Aa MA; Van Gorp T; Van Nieuwenhuysen E; van-Wagensveld L; Wahner-Hendrickson AE; Walter C; Wang C; Welz J; Wentzensen N; Wilkens LR; Winham SJ; Winterhoff B; Anglesio MS; Berchuck A; Candido Dos Reis FJ; Cohen PA; Conrads TP; Crowe P; Doherty JA; Fasching PA; Fortner RT; García MJ; Gayther SA; Goodman MT; Gronwald J; Harris HR; Heitz F; Horlings HM; Karlan BY; Kelemen LE; Maxwell GL; Menon U; Modugno F; Neuhausen SL; Schildkraut JM; Staebler A; Sundfeldt K; Swerdlow AJ; Vergote I; Wu AH; Brenton JD; Pharoah PDP; Pearce CL; Pike MC; Goode EL; Ramus SJ; Köbel M; Nelson BH; DeFazio A; Friedlander ML; Bowtell DDL; Garsed DW, 2025, Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma., http://dx.doi.org/10.1101/2025.09.17.25335919

Heinze K; Nazeran T; Lee S; Krämer P; Cairns E; Chiu D; Leung SCY; Kang EY; Meagher N; Kennedy C; Boros J; Kommoss F; Vollert H-W; Heitze F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FKF; Heublein S; Sinn H-P; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand A; Harnett P; DeFazio A; Fortner R; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy M; Jones M; Schoemaker M; Swerdlow A; Gorringe K; Campbell I; Cook L; Gayther S; Carney M; Shvetsov Y; Hernandez B; Wilkens L; Goodman M; Mateoiu C; Linder A; Sundfeldt K; Kelemen L; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton K; Alsop J; Shah M; Jimenez-Linan M; Pharoah PDP; Brenton J; Cushing-Haugen K; Harris H; Doherty J; Gilks B; Ghatage P; Huntsman D; Nelson G; Tinker A; Lee C-H; Goode E; Nelson B; Ramus S; Kommoss S; Talhouk A; Köbel M; Anglesio M, 2021, Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma, http://dx.doi.org/10.1101/2021.09.16.21262993

Back to profile page